| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A novel inhibitor of ARfl and ARv7 induces protein degradation to overcome enzalutamide resistance in advanced prostate cancer
|
Li, Yan
|
|
|
12 |
11 |
p. 4165-4179
|
article
|
| 2 |
A potent PGK1 antagonist reveals PGK1 regulates the production of IL-1β and IL-6
|
Liao, Liping
|
|
|
12 |
11 |
p. 4180-4192
|
article
|
| 3 |
Biosynthesis of rumbrins and inspiration for discovery of HIV inhibitors
|
Zhong, Beifen
|
|
|
12 |
11 |
p. 4193-4203
|
article
|
| 4 |
Broad-spectrum and powerful neutralization of bacterial toxins by erythroliposomes with the help of macrophage uptake and degradation
|
Liu, Chunying
|
|
|
12 |
11 |
p. 4235-4248
|
article
|
| 5 |
Cardiac fibroblast heat shock protein 47 aggravates cardiac fibrosis post myocardial ischemia–reperfusion injury by encouraging ubiquitin specific peptidase 10 dependent Smad4 deubiquitination
|
Xie, Saiyang
|
|
|
12 |
11 |
p. 4138-4153
|
article
|
| 6 |
Cascade two-stage tumor re-oxygenation and immune re-sensitization mediated by self-assembled albumin-sorafenib nanoparticles for enhanced photodynamic immunotherapy
|
Zhou, Zaigang
|
|
|
12 |
11 |
p. 4204-4223
|
article
|
| 7 |
Cover Story
|
|
|
|
12 |
11 |
p. viii
|
article
|
| 8 |
Drug discovery in China: A snapshot of recent progress
|
Hu, Hongxi
|
|
|
12 |
11 |
p. 4266-4269
|
article
|
| 9 |
Emerging biotechnology applications in natural product and synthetic pharmaceutical analyses
|
Chen, Shilin
|
|
|
12 |
11 |
p. 4075-4097
|
article
|
| 10 |
New opportunities and challenges of natural products research: When target identification meets single-cell multiomics
|
Zhu, Yuyu
|
|
|
12 |
11 |
p. 4011-4039
|
article
|
| 11 |
Novel dual inhibitor for targeting PIM1 and FGFR1 kinases inhibits colorectal cancer growth in vitro and patient-derived xenografts in vivo
|
Yin, Fanxiang
|
|
|
12 |
11 |
p. 4122-4137
|
article
|
| 12 |
PROTAC technology as a novel tool to identify the target of lathyrane diterpenoids
|
Wu, Yanli
|
|
|
12 |
11 |
p. 4262-4265
|
article
|
| 13 |
Schaftoside inhibits 3CLpro and PLpro of SARS-CoV-2 virus and regulates immune response and inflammation of host cells for the treatment of COVID-19
|
Yi, Yang
|
|
|
12 |
11 |
p. 4154-4164
|
article
|
| 14 |
Site-selective oral delivery of therapeutic antibodies to the inflamed colon via a folic acid-grafted organic/inorganic hybrid nanocomposite system
|
Lee, Sang Hoon
|
|
|
12 |
11 |
p. 4249-4261
|
article
|
| 15 |
Small molecules for combating multidrug-resistant superbug Candida auris infections
|
Tu, Jie
|
|
|
12 |
11 |
p. 4056-4074
|
article
|
| 16 |
Smart drug delivery systems for precise cancer therapy
|
Wang, Xiaoyou
|
|
|
12 |
11 |
p. 4098-4121
|
article
|
| 17 |
Table of Contents
|
|
|
|
12 |
11 |
p. iii-viii
|
article
|
| 18 |
The anti-inflammatory feature of glucagon-like peptide-1 and its based diabetes drugs—Therapeutic potential exploration in lung injury
|
Pang, Juan
|
|
|
12 |
11 |
p. 4040-4055
|
article
|
| 19 |
Tumor-microenvironment activated duplex genome-editing nanoprodrug for sensitized near-infrared titania phototherapy
|
Li, Zekun
|
|
|
12 |
11 |
p. 4224-4234
|
article
|
Journal description